An international company with a broad portfolio of hospital-use drugs faced the loss of Medicare reimbursement for several products commonly used in outpatient settings. The Centers for Medicare…
Read more
A client health system came to Applied Policy when it faced an untenable choice: either turn away Medicare beneficiaries with intrahepatic cholangiocarcinoma (iCCA) or absorb the $800,000 to…
Read more
Our client, a long-established medical device supplier, has built a national reputation for leadership in integrated diabetes management. By combining technological innovation and patient-centered design, the company brings…
Read more
A physician-owned health system serving more than 1.3 million residents through general acute care services, graduate medical education, and wellness and preventative programs across 70 sub-specialties faced a…
Read moreA durable medical equipment (DME) supplier delivering insulin pumps and related supplies sought crossover claim reimbursement for Qualified Medicare Beneficiaries (QMBs) in a Northeastern state. Although the supplier…
Read moreA pharmaceutical manufacturer preparing to launch a new antibiotic in the inpatient hospital setting faced a significant reimbursement barrier. Under Medicare’s Inpatient Prospective Payment System (IPPS), hospital services…
Read moreA global pharmaceutical manufacturer turned to Applied Policy for strategic guidance as the Centers for Medicare & Medicaid Services (CMS) introduced emerging bundled payment initiatives. The client, based…
Read moreNo case studies match your filters.
